局灶性先天性肝血管瘤的自发演变模式:25例病例系列
该回顾性病例系列纳入25例2000—2018年诊断的局灶性先天性肝血管瘤患儿,随访中位46.5个月,8例(32%)出现出生后增长后再消退,17例(68%)体积持续减小(15例完全消退、2例部分消退);不同演变模式的初始超声特征重叠,未发现与出生后增长显著相关的初始超声特征。
要点
- 局灶性先天性肝血管瘤并非均与皮肤RICH等同,部分可出生后增长后再消退。
- 25例中8例(32%)出生后增长后消退,17例(68%)体积持续减小。
- 不同演变模式的初始超声特征重叠,未发现预测出生后增长的初始超声特征。
核心结论
- 局灶性先天性肝血管瘤不等同于皮肤RICH,部分可增大且消退可快可慢;不同演变模式的超声特征重叠。
研究设计与样本
- 回顾性病例系列,纳入2000—2018年诊断的25例局灶性先天性肝血管瘤患儿(产前诊断或诊断年龄<7天和/或GLUT1阴性肿瘤),中位随访46.5个月(范围4—144个月),基于超声和横断面影像用标准椭球公式估算体积。
关键影像表现/征象
- 8例(32%)病灶在消退前出现出生后增长,无病灶内出血征象。
- 17例(68%)病灶体积随年龄严格减小,其中15例完全消退(8例在18月龄前、7例在18月龄后),2例部分消退。
- 8例快速消退病灶中3例超声见大血管腔伴显著血供。
- 不同演变模式的影像特征重叠。
临床应用与阅片要点
- 分析肿瘤体积变化时假定35%的误差范围以校正测量变异。
- 初始产后超声特征与演变模式相关分析未发现与出生后增长显著相关的特征。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Hepatic hemangiomas are the most common benign liver tumors of infancy. They are termed congenital if fully developed at birth or infantile if they appear in the first weeks of life. Previous studies suggested that most focal hepatic hemangiomas are congenital in nature, exhibit no postnatal growth and have an evolution that parallels their cutaneous counterparts. They are subdivided by pattern of involution, whether rapidly involuting (RICH), partially involuting (PICH) or non-involuting (NICH) congenital hemangiomas. In our experience, some focal hepatic hemangiomas show postnatal growth, behaving like infantile forms.
OBJECTIVES: To analyze the spontaneous evolution of focal congenital hepatic hemangiomas with quantification of tumor volume changes over time and to identify initial postnatal ultrasound (US) imaging biomarkers predictive of their evolution pattern.
MATERIALS AND METHODS: A retrospective review of clinical, imaging and pathology data of children diagnosed with focal congenital hepatic hemangioma (prenatal diagnosis or age at diagnosis <7 days and/or glucose transporter protein 1 [GLUT1]-negative tumor) diagnosed between 2000 and 2018 was performed with analysis of tumor volume changes over time. Exclusion criteria were treatment inducing a tumor volume change (hepatic artery embolization, propranolol, or corticosteroids), imaging follow-up less than 1 month or fewer than two US examinations. Volumetric analysis was based on US and cross-sectional imaging. Lesion volumes were estimated using the standard ellipsoid formula. A 35% margin of error was assumed for tumor volume variation to account for variability in measurements. Imaging studies, including US, computed tomography, and magnetic resonance imaging, were reviewed and initial postnatal US features were correlated with evolution pattern.
RESULTS: Twenty-five patients with focal congenital hepatic hemangiomas were included. The median follow-up time was 46.5 months (range: 4-144 months). Eight (32%) lesions showed postnatal growth before involuting, without signs of intralesional hemorrhage, as do cutaneous infantile hemangiomas. The other 17 (68%) lesions exhibited a strict decrease in volume with age, of which 15 underwent complete involution (8 before age 18 months and 7 after age 18 months) and 2 underwent partial involution. The different evolution patterns of focal congenital hepatic hemangiomas showed overlapping imaging features and we found no initial US feature to be significantly associated with postnatal growth. However, large vascular spaces with marked vascularity at US were noted in three of the eight rapidly involuting lesions.
CONCLUSION: Focal congenital hepatic hemangiomas are not the equivalent of cutaneous RICH, as some may increase in size and tumor regression may be rapid or slow. The different evolution patterns of focal congenital hepatic hemangiomas show overlapping US features.
引用
- Rutten, Ladarre, Ackermann, et al. Spontaneous evolution patterns of focal congenital hepatic hemangiomas: a case series of 25 patients. Pediatr Radiol. 2022. PMID: 35229180. doi:10.1007/s00247-021-05277-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。